The future of dengue vaccines

This publication has 23 references indexed in Scilit:

• Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever
  The Lancet, 2002
• Derivation and Characterization of a Dengue Type 1 Host Range-Restricted Mutant Virus That Is Attenuated and Highly Immunogenic in Monkeys
  Journal of Virology, 2002
• Strong HLA Class I–Restricted T Cell Responses in Dengue Hemorrhagic Fever: A Double‐Edged Sword?
  The Journal of Infectious Diseases, 2001
• Acute Management of Dengue Shock Syndrome: A Randomized Double-Blind Comparison of 4 Intravenous Fluid Regimens in the First Hour
  Clinical Infectious Diseases, 2001
• Chimeric Dengue Type 2 (Vaccine Strain PDK-53)/Dengue Type 1 Virus as a Potential Candidate Dengue Type 1 Virus Vaccine
  Journal of Virology, 2000
• Age-related changes in microvascular permeability: a significant factor in the susceptibility of children to shock?
  Clinical Science, 2000
• Dengue Viremia Titer, Antibody Response Pattern, and Virus Serotype Correlate with Disease Severity
  The Journal of Infectious Diseases, 2000
• Fluid Replacement in Dengue Shock Syndrome: A Randomized, Double‐Blind Comparison of Four Intravenous‐Fluid Regimens
  Clinical Infectious Diseases, 1999
• Antibodies that block virus attachment to vero cells are a major component of the human neutralizing antibody response against dengue virus type 2
  Journal of Medical Virology, 1995
• Pathogenesis of Dengue: Challenges to Molecular Biology
  Science, 1988